Cancer and aging have gone hand in hand for many years, and the cure for cancer has become, over long years of research, not as simple as one miracle drug or technique. International hospitals in Bangkok and Asian medical tourism facilities use their lower costs and advanced technologies to help many people that would have been untreatable in their home countries, however, prevention is always seen as better than cure. The breakthrough that has given the most hope in recent times is a compound that has been undergoing extensive laboratory testing, and was recently shown to be effective in killing all 12 types of cancer.

There have been several cancer prevention pills and compounds developed in recent years, or published as being under development. For example, Thailand breast cancer centers and cancer regular checkup providers have been eagerly anticipating a once-a-day pill, using a palm oil derivative mainly containing vitamin E, tocotrineol, which could not only help prevent breast cancer developing, but treat the early signs of the disease without going to a Thailand cancer center. The joint venture between researchers in Australia and Hong Kong, a major Asian medical tourism country, say that the inexpensive method could save thousands of lives every month.

Cancer prevention is also named as one of the main reasons that the vitamin and natural supplement industry is now worth $ 18 billion per year in the US. Baby boomers fear the cancer, osteoporosis and heart disease that affect their generation more than any other, currently, and are spending up big trying to avoid the need for Thailand cancer centers and breast cancer treatment in Thailand.

The new compound, though developed by researchers at University of Oklahoma Health Sciences Center, is expected to eventually become a daily pill that would be taken to prevent many types of cancer forming, not only one. Doris Benbrook, the principal investiogator in the team, says that the compound destroyed all 12 of the types of cancer that the lab tested it on. The pill contains a flex-Het drug, SHetA2, which targets abnormalities in cancer cell components, and leaves normal cells unharmed. Thailand cancer centers and international hospitals in Thailand could prescribe this to at risk patients, and even those in lower risk categories.

The researchers are also looking at using the synthetic Flex-Het compounds to treat polycystic kidney disease, kidney cancer and ovarian cancer. The pill would also be a significant boon to cancer survivors that have already undergone bone cancer treatment and other treatment at Thailand cancer centers, or are in the midst of it. These patients experience severe toxicity from the effects of their treatment, and the synthetic compound is much easier on the body. It will be especially useful for cancer survivors whose disease was late stage, and still have a short life expectancy despite undergoing radiation. It is being touted as similar to a multi-vitamin, to be taken daily as a purely preventative measure. The compound has been patented, and the team hopes that the drug will be refined enough for them to start clinical trials at international hospitals in Bangkok and elsewhere within 5 years.